HaiBiPing ® Valsartan/Amlodipine Tablets (Ⅰ)
Selected in the 4th round of National Volume-Based Procurement organized by
the National Essential Drugs, Category B under Medical Insurance
[Drug Name]
Generic Name: Valsartan/Amlodipine Tablets
[Indications]
For the treatment of essential hypertension.
This product is indicated in patients whose blood pressure is not adequately controlled by monotherapy.
[Dosage and Administration]
Amlodipine at a daily dose of 2.5 mg to 10 mg is effective in treating hypertension, while effective valsartan doses range from 80 mg to 320 mg.
In clinical trials with once-daily valsartan/amlodipine tablets, doses of 5–10 mg amlodipine and 80–320 mg valsartan produced dose-dependent antihypertensive effects.
Patients whose blood pressure is inadequately controlled by monotherapy may switch to this product.
Amlodipine and valsartan can be taken with or without food. This product is recommended to be taken with water.
[Contraindications]
Contraindicated in patients allergic to the active ingredients or any excipients of this product.
For more details, please refer to the package insert.
[Specification]
5 mg/80 mg (calculated as amlodipine/valsartan)
[Shelf Life]
36 months
[Approval Number]
National Medical Products Administration Approval Number：H20223239
Fujian Haixi New Pharmaceutical Creation Co., Ltd. Fujian ICP Record No. 12015727 Internet Drug Information Service Qualification Certificate No.: (Min) - Non-operating-2023-0063
Some of the text and pictures on this site are from the Internet and are only used for sharing and learning. If your rights and interests are infringed, please inform us in time, and this site will deal with or replace them in time.
